Endowment Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
2,936
-26
-0.9% -$2.1K 0.09% 153
2026
Q1
$257K Buy
2,962
+118
+4% +$11.3K 0.11% 130
2025
Q4
$273K Sell
2,844
-31
-1% -$3.01K 0.13% 112
2025
Q3
$274K Sell
2,875
-4
-0.1% -$368 0.12% 119
2025
Q2
$251K Buy
2,879
+149
+5% +$12.6K 0.13% 123
2025
Q1
$245K Sell
2,730
-43
-2% -$3.85K 0.16% 118
2024
Q4
$222K Buy
2,773
+375
+16% +$32.5K 0.15% 124
2024
Q3
$216K Buy
+2,398
New +$202K 0.14% 119

Other funds holding MDT

Endowment Wealth Management's MDT Position: Q2 2026 in Review

Endowment Wealth Management reduced its Medtronic (MDT) stake by 0.88% in Q2 2026, selling an estimated $2.1K and leaving 2,936 shares worth $230K. The position accounts for 0.09% of the portfolio, ranked #153.

Endowment Wealth Management first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $274K in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Endowment Wealth Management held 2,936 shares of Medtronic worth $230K as of Q2 2026.
  • Endowment Wealth Management sold 26 Medtronic shares in Q2 2026, an estimated $2.1K.
  • Medtronic made up 0.09% of Endowment Wealth Management's portfolio in Q2 2026, its #153 holding.
  • Endowment Wealth Management first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Endowment Wealth Management's Medtronic position peaked at $274K in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Endowment Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.